CLARITY Visual Read Antigen Test "CLIA WAIVED" 25/box
Clarity is pleased to provide a new line of dependable COVID-19 solutions in response to the global pandemic. Our Pathway C EUA-approved COVID-19 products are proudly made in Finland. Since there is still a pandemic going on, it is crucial to have trustworthy testing and precise findings. For this reason, our COVID devices are designed to be quick, simple to use, and most importantly, accurate.
Important Information
- This test is not approved for OTC use or At-Home use.
- The Clarity COVID-19 Antigen test can be used to test directly collected naso-pharyngeal swab specimens.
- The Clarity COVID-19 Antigen test should be ordered for the detection of COVID-19 antigen in individuals who are suspected of COVID-19 by their healthcare provider and who are within six days of symptom onset.
- The Clarity COVID-19 Antigen test is authorized for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high complexity, moderate complexity, or waived tests. This test is authorized for use at the Point of Care (POC), i.e., patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Our CLIA Waiver can be found on the FDA’s website at the following link: https://www.fda.gov/media/149056/download
